- Home
- DYN vs ARCO Comparison
DYN vs ARCO Comparison
Compare DYN & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ARCO
- Stock Information
- Founded
- DYN 1984
- ARCO 2007
- Country
- DYN United States
- ARCO Uruguay
- Employees
- DYN N/A
- ARCO N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ARCO Restaurants
- Sector
- DYN Health Care
- ARCO Consumer Discretionary
- Exchange
- DYN Nasdaq
- ARCO Nasdaq
- Market Cap
- DYN 1.4B
- ARCO 1.6B
- IPO Year
- DYN 2020
- ARCO 2011
- Fundamental
- Price
- DYN $9.67
- ARCO $7.73
- Analyst Decision
- DYN Strong Buy
- ARCO Buy
- Analyst Count
- DYN 15
- ARCO 1
- Target Price
- DYN $43.60
- ARCO $12.00
- AVG Volume (30 Days)
- DYN 2.8M
- ARCO 1.4M
- Earning Date
- DYN 08-11-2025
- ARCO 08-13-2025
- Dividend Yield
- DYN N/A
- ARCO 3.06%
- EPS Growth
- DYN N/A
- ARCO N/A
- EPS
- DYN N/A
- ARCO 0.64
- Revenue
- DYN N/A
- ARCO $4,465,398,000.00
- Revenue This Year
- DYN N/A
- ARCO $7.11
- Revenue Next Year
- DYN N/A
- ARCO $8.15
- P/E Ratio
- DYN N/A
- ARCO $12.21
- Revenue Growth
- DYN N/A
- ARCO 0.97
- 52 Week Low
- DYN $6.36
- ARCO $6.66
- 52 Week High
- DYN $47.45
- ARCO $10.55
- Technical
- Relative Strength Index (RSI)
- DYN 32.17
- ARCO 56.76
- Support Level
- DYN $10.00
- ARCO $7.46
- Resistance Level
- DYN $10.74
- ARCO $7.72
- Average True Range (ATR)
- DYN 0.88
- ARCO 0.15
- MACD
- DYN -0.48
- ARCO 0.02
- Stochastic Oscillator
- DYN 0.53
- ARCO 83.33
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About ARCO Arcos Dorados Holdings Inc. Shares
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.